-
Contact Lens Devised to Measure Glaucoma Eye Pressure
Engineers in the U.K. developed a soft contact lens that in a clinical study shows it can reliably track changes in pressure inside the eye, a key factor in glaucoma.
-
Live Skin Bacteria Shown to Control Acne
First results of a clinical trial show a spray-on formulation of live bacteria reduced the amount and severity of acne in people with mild to moderate cases of the condition.
-
Snake-Like Intelligent Robot in Development
An engineering team is creating a self-powered robot that can travel independently like a snake through uneven and cluttered surfaces, such as disaster sites.
-
Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal
Drug maker Eli Lilly and Company and biotechnology company CureVac AG agreed to develop a series of cancer immunotherapies based on CureVac’s messenger RNA technology.
-
Phone App Screens for Postpartum Depression
A new smartphone app helps detect depression among women who recently gave birth, and optionally gathers data for continued research on the disorder.
-
Scientifically-Proven Ways to Make Your Employees Happier
To turn to science to find the things that are proven to make employees happier. You can look at business studies, as well as psychological theories and phenomena.
-
First Trial of Alzheimer’s Drug Underway
The first clinical trial is underway of a therapy for stopping the progression of Alzheimer’s disease that purports to rebuild neural connections in the brain.
-
Univ. Spin-Off Reports Cancer Immunotherapy Advance
A highly targeted synthetic antibody, developed by a university spin-off enterprise, was shown to destroy human breast cancer cells grafted in lab mice.
-
Online Game Harnessed to Combat Foodborne Toxins
A consortium of companies and university labs is recruiting participants in an online computer game to design synthetic proteins to neutralize a toxin that contaminates food crops.
-
Roche, Biotech to Discover New Antibiotics
A biotechnology company that discovers new drugs through detailed genomic analysis is partnering with drug maker Roche to find new treatments for bacterial infections that resist current antibiotics.